Low dose mitomycin-C in severe vernal keratoconjunctivitis: a randomized prospective double blind study.


PURPOSE To study the efficacy and safety of low dose topical Mitomycin C (MMC) in severe Vernal keratoconjunctivitis (VKC). DESIGN Placebo controlled double masked randomized clinical trial. MATERIALS AND METHODS Twenty-eight patients with severe VKC were randomly assigned to receive either topical MMC (0.01%) (n=17) or distilled water (n=11) three… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.